The Fourth High-Quality Development Conference for Traditional Chinese Medicine was held in Wuzhen, Zhejiang province, on April 23. The conference announced the release of the "2025 International High-Impact Research in Traditional Chinese Medicine and Traditional Medicine."

Supported by the China Institute of Science and Technology Information and the Chinese Association of Chinese Medicine, the project was jointly implemented by the editorial department of Acupuncture and Herbal Medicine and Wolters Kluwer, a global information services company headquartered in the Netherlands. The initiative aims to promote the inheritance, innovation, and global sharing of modernized TCM research.

The selection process evaluated studies across five dimensions: journal impact, article impact, author influence, public influence, and research impact. Through nominations, supplementary entries and public voting, a high-impact research database was created. After online voting, reviews by nearly 100 peer experts, and final approval by industry leaders, 50 studies were selected.

The selected studies cover seven fields, including acupuncture research, clinical research, and medicinal resource studies. Among them, 33 were completed independently by Chinese institutions, 13 were collaborative efforts involving 27 institutions from nine countries, and four studies were conducted by foreign institutions in the United States and Iran.

Prominent experts including Zhang Boli, an academician at the Chinese Academy of Engineering and a TCM expert, attended the release ceremony. The announcement emphasized the role of these studies in advancing global collaboration and scientific progress in traditional medicine.